118 related articles for article (PubMed ID: 36478296)
1. Effects of the SLCO1B1 A388G single nucleotide polymorphism on the development, clinical parameters, treatment, and survival of multiple myeloma cases in a Polish population.
Michalska K; Balcerczak E; Jeleń A; Saed L; Pietrzak J; Żebrowska-Nawrocka M
Mol Biol Rep; 2023 Feb; 50(2):1447-1458. PubMed ID: 36478296
[TBL] [Abstract][Full Text] [Related]
2. [OATP 1B1 T521C/A388G is an important polymorphism gene related to neonatal hyperbilirubinemia].
Zhang HX; Zhao X; Yang Z; Peng CY; Long R; Li GN; Li J; He ZK
Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):650-5. PubMed ID: 21092521
[TBL] [Abstract][Full Text] [Related]
3. Do MDR1 and SLCO1B1 polymorphisms influence the therapeutic response to atorvastatin? A study on a cohort of Egyptian patients with hypercholesterolemia.
Shabana MF; Mishriki AA; Issac MS; Bakhoum SW
Mol Diagn Ther; 2013 Oct; 17(5):299-309. PubMed ID: 23677857
[TBL] [Abstract][Full Text] [Related]
4. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
Cavo M; Gay F; Beksac M; Pantani L; Petrucci MT; Dimopoulos MA; Dozza L; van der Holt B; Zweegman S; Oliva S; van der Velden VHJ; Zamagni E; Palumbo GA; Patriarca F; Montefusco V; Galli M; Maisnar V; Gamberi B; Hansson M; Belotti A; Pour L; Ypma P; Grasso M; Croockewit A; Ballanti S; Offidani M; Vincelli ID; Zambello R; Liberati AM; Andersen NF; Broijl A; Troia R; Pascarella A; Benevolo G; Levin MD; Bos G; Ludwig H; Aquino S; Morelli AM; Wu KL; Boersma R; Hajek R; Durian M; von dem Borne PA; Caravita di Toritto T; Zander T; Driessen C; Specchia G; Waage A; Gimsing P; Mellqvist UH; van Marwijk Kooy M; Minnema M; Mandigers C; Cafro AM; Palmas A; Carvalho S; Spencer A; Boccadoro M; Sonneveld P
Lancet Haematol; 2020 Jun; 7(6):e456-e468. PubMed ID: 32359506
[TBL] [Abstract][Full Text] [Related]
5. Association of ABCB1 T-129C polymorphism and multiple myeloma risk in Polish population.
Niebudek K; Balcerczak E; Mirowski M; Żebrowska M
Pol J Pathol; 2018; 69(4):405-409. PubMed ID: 30786691
[TBL] [Abstract][Full Text] [Related]
6. Frequency of functional exonic single-nucleotide polymorphisms and haplotype distribution in the SLCO1B1 gene across genetic ancestry groups in the Qatari population.
Dashti M; Al-Matrouk A; Channanath A; Al-Mulla F; Thanaraj TA
Sci Rep; 2022 Sep; 12(1):14858. PubMed ID: 36050458
[TBL] [Abstract][Full Text] [Related]
7. A Single Nucleotide Polymorphism (SNP) in the
Li J; Persaud AK; Johnson JA; Sborov DW; Phelps MA; Hofmeister CC; Poi MJ
Anticancer Res; 2022 Jan; 42(1):385-395. PubMed ID: 34969749
[TBL] [Abstract][Full Text] [Related]
8. Repaglinide-irbesartan drug interaction: effects of SLCO1B1 polymorphism on repaglinide pharmacokinetics and pharmacodynamics in Chinese population.
Pei Q; Liu JY; Yin JY; Yang GP; Liu SK; Zheng Y; Xie P; Guo CX; Luo M; Zhou HH; Li X; Liu ZQ
Eur J Clin Pharmacol; 2018 Aug; 74(8):1021-1028. PubMed ID: 29748863
[TBL] [Abstract][Full Text] [Related]
9. The SNPs rs429358 and rs7412 of APOE gene are association with cerebral infarction but not SNPs rs2306283 and rs4149056 of SLCO1B1 gene in southern Chinese Hakka population.
Wu H; Huang Q; Yu Z; Wu H; Zhong Z
Lipids Health Dis; 2020 Sep; 19(1):202. PubMed ID: 32891149
[TBL] [Abstract][Full Text] [Related]
10. High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1).
Niemi M; Schaeffeler E; Lang T; Fromm MF; Neuvonen M; Kyrklund C; Backman JT; Kerb R; Schwab M; Neuvonen PJ; Eichelbaum M; Kivistö KT
Pharmacogenetics; 2004 Jul; 14(7):429-40. PubMed ID: 15226675
[TBL] [Abstract][Full Text] [Related]
11. Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial.
Mateos MV; Cavo M; Blade J; Dimopoulos MA; Suzuki K; Jakubowiak A; Knop S; Doyen C; Lucio P; Nagy Z; Pour L; Cook M; Grosicki S; Crepaldi A; Liberati AM; Campbell P; Shelekhova T; Yoon SS; Iosava G; Fujisaki T; Garg M; Krevvata M; Chen Y; Wang J; Kudva A; Ukropec J; Wroblewski S; Qi M; Kobos R; San-Miguel J
Lancet; 2020 Jan; 395(10218):132-141. PubMed ID: 31836199
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of nuclear factor-κB family genes are associated with development of multiple myeloma and treatment outcome in patients receiving bortezomib-based regimens.
Du J; Huo J; Shi J; Yuan Z; Zhang C; Fu W; Jiang H; Yi Q; Hou J
Haematologica; 2011 May; 96(5):729-37. PubMed ID: 21228035
[TBL] [Abstract][Full Text] [Related]
13. Organic anion transporter protein (OATP1B1) encoded by SLCO1B1 gene polymorphism (388A>G) & susceptibility in gallstone disease.
Jindal C; Kumar S; Choudhari G; Goel H; Mittal B
Indian J Med Res; 2009 Feb; 129(2):170-5. PubMed ID: 19293444
[TBL] [Abstract][Full Text] [Related]
14.
Božina T; Ganoci L; Karačić E; Šimičević L; Vrkić-Kirhmajer M; Klarica-Domjanović I; Križ T; Sertić Z; Božina N
Ann Hum Biol; 2022 Dec; 49(7-8):323-331. PubMed ID: 36382878
[TBL] [Abstract][Full Text] [Related]
15. The use of low-dose prednisone and melphalan in the treatment of poor-risk patients with multiple myeloma.
Cuttner J; Wasserman LR; Martz G; Sonntag RW; Kyle RA; Silver RT; Spurr C; Harley JB; Wiernik PM; Cornwell GG; Falkson G; Glidewell O; Holland JF
Med Pediatr Oncol; 1975; 1(3):207-16. PubMed ID: 1232529
[TBL] [Abstract][Full Text] [Related]
16. A combination of melphalan, prednisone, and 50 mg thalidomide treatment in non-transplant-candidate patients with newly diagnosed multiple myeloma.
Chang HJ; Lee JH; Do YR; Bae SH; Lee JL; Nam SH; Yoon SS; Bang SM
Korean J Intern Med; 2011 Dec; 26(4):403-9. PubMed ID: 22205840
[TBL] [Abstract][Full Text] [Related]
17. Effects of two functionally important SLCO1B1 gene polymorphisms on pharmacokinetics of atorvastatin.
Rajput TA; Naveed AK; Farooqi ZR; Khan S
Pak J Pharm Sci; 2017 Jul; 30(4):1363-1370. PubMed ID: 29039339
[TBL] [Abstract][Full Text] [Related]
18. A single nucleotide polymorphism in SLC7A5 is associated with gastrointestinal toxicity after high-dose melphalan and autologous stem cell transplantation for multiple myeloma.
Giglia JL; White MJ; Hart AJ; Toro JJ; Freytes CO; Holt CC; Cai Y; Williams SM; Brandt SJ
Biol Blood Marrow Transplant; 2014 Jul; 20(7):1014-20. PubMed ID: 24704384
[TBL] [Abstract][Full Text] [Related]
19. Unveiling molecular associations of polymorphic variants of VDR gene (FokI, BsmI and ApaI) in multiple myeloma patients of Indian population.
Kumar R; Himani ; Gupta N; Singh V; Kumar V; Haq A; Mirza AA; Sharma A
J Steroid Biochem Mol Biol; 2020 May; 199():105588. PubMed ID: 32004705
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of TNF alpha, LT alpha, MDR1 and codon 72 Tp53 gene polymorphisms on multiple myeloma Egyptian patients.
Hegazi HM; Elghonemy MS; El-Baiomy MA; Soliman EA; Abdel-Hady EK
Leuk Res; 2022 Jun; 117():106854. PubMed ID: 35594781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
